Drug laws and licensing
Advisory Council on the Misuse of Drugs
The Advisory Council on the Misuse of Drugs (ACMD) is an independent expert body that advises government on drug related issues in the UK.
It was established under the Misuse of Drugs Act 1971.
The Advisory Council makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regulations. It considers any substance which is being or appears to be misused and of which is having or appears to be capable of having harmful effects sufficient to cause a social problem.
It also carries out in-depth inquiries into aspects of drug use that are causing particular concern in the UK, with the aim of producing considered reports that will be helpful to policy makers and practitioners.
What's New
- Home Secretary bans mephedrone
- ACMD report on the consideration of the cathinones
- Three appointments to ACMD (Advisory Council on the Misuse of Drugs)
- ACMD: Pathways to Problems - a follow-up report on the implementation of recommendations from Pathways to Problems report
- ACMD open meeting agenda - 29 March 2010
- Home Secretary (Alan Johnson) letter to Professor Les Iverson - March 2010
- ACMD letter to the Home Secretary (Alan Johnson) - February 2010
- ACMD recruitment campaign 2010
- Professor Les Iversen appointed new ACMD interim chair
- ACMD letter to Home Secretary - Mephedrone (and related cathinones)
- Joint Statement from the Home Secretary and the Advisory Council on the Misuse of Drugs
- Review of the Advisory Council on the Misuse of Drugs (ACMD) 2009
-
Useful information about the council
-
Minutes and documents for ACMD meetings.
-
Drug-specific, inquiry and annual reports.
-
You are entitled to receive information under the Freedom of information Act, unless exceptions apply.
-
A full list of Advisory Council publications.
